Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current Stimulation

NIH's ClinicalTrials.gov registry added a new clinical trial (NCT07534397) for a study examining high-definition transcranial direct current stimulation (tDCS) as a treatment for cognitive and sensorimotor deficits in Parkinson's disease. The trial will use active tDCS versus sham stimulation as comparator interventions. The study is registered with an estimated start date of April 16, 2026.

For compliance officers, this registry entry indicates a forthcoming clinical investigation involving a non-invasive brain stimulation device. Researchers and sponsors should ensure any tDCS protocols align with applicable FDA guidance on experimental device use and IRB oversight requirements.